Cache (CACH) June Comps Up 6%, Guides Higher
Tweet
Share
E-mailGet Alerts CACH Hot Sheet
Price: $0.00 --0%
Financial Fact:
Operating income (loss): -11.48M
Today's EPS Names:
SUJA, SQNS, ANGI, More
Financial Fact:
Operating income (loss): -11.48M
Today's EPS Names:
SUJA, SQNS, ANGI, More
Join SI Premium – FREE
Cache Inc. (NASDAQ: CACH) June comparable store sales rose 6%.
Cache expects second quarter EPS in the range of $0.14 to $0.15, which compares to its previous expectation for second quarter fiscal 2008 diluted earnings per share of $0.12 to $0.14. The Wall Street consensus is $0.14.
For the full fiscal 2008 year, the Company is introducing sales guidance in the range of $286 million to $290 million and guidance for diluted earnings per share on a GAAP basis in the range of $0.38 to $0.42. On an adjusted basis, excluding store closing and management change costs the Company expects fiscal 2008 diluted earnings per share in the range of $0.52 to $0.56. The Wall Street consensus is revenues of $280.5 million and EPS of $0.54.
Cache expects second quarter EPS in the range of $0.14 to $0.15, which compares to its previous expectation for second quarter fiscal 2008 diluted earnings per share of $0.12 to $0.14. The Wall Street consensus is $0.14.
For the full fiscal 2008 year, the Company is introducing sales guidance in the range of $286 million to $290 million and guidance for diluted earnings per share on a GAAP basis in the range of $0.38 to $0.42. On an adjusted basis, excluding store closing and management change costs the Company expects fiscal 2008 diluted earnings per share in the range of $0.52 to $0.56. The Wall Street consensus is revenues of $280.5 million and EPS of $0.54.
You May Also Be Interested In
- Spotify earnings preview Q2: stronger print expected on user growth, price hikes
- Otter Tail Corp (OTTR) Tops Q2 EPS by 15c; offers guidance
- aTyr Pharma (LIFE) Reports Q2 EPS of $0.53 ; Offers Guidance
Create E-mail Alert Related Categories
Guidance, Hot List, Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
